IGC Pharma
27 hedge funds and large institutions have $1.01M invested in IGC Pharma in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.24% more ownership
Funds ownership: 5% → 5.24% (+0.24%)
Holders
27
Holding in Top 10
–
Calls
$48K
Puts
$11K
Top Buyers
| 1 | +$40K | |
| 2 | +$25K | |
| 3 | +$16.7K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$11.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.96K |
Top Sellers
| 1 | -$27K | |
| 2 | -$13.6K | |
| 3 | -$7.4K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$495 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$20 |